Annual Current Ratio
10.79
+1.37+14.54%
December 31, 2023
Summary
- As of February 8, 2025, PRLD annual current ratio is 10.79, with the most recent change of +1.37 (+14.54%) on December 31, 2023.
- During the last 3 years, PRLD annual current ratio has fallen by -8.62 (-44.41%).
- PRLD annual current ratio is now -44.41% below its all-time high of 19.41, reached on December 31, 2020.
Performance
PRLD Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
7.04
-0.79-10.09%
September 30, 2024
Summary
- As of February 8, 2025, PRLD quarterly current ratio is 7.04, with the most recent change of -0.79 (-10.09%) on September 30, 2024.
- Over the past year, PRLD quarterly current ratio has dropped by -4.60 (-39.52%).
- PRLD quarterly current ratio is now -76.04% below its all-time high of 29.38, reached on March 31, 2021.
Performance
PRLD Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
PRLD Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.5% | -39.5% |
| 3 y3 years | -44.4% | -25.3% |
| 5 y5 years | +69.4% | -25.3% |
PRLD Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.8% | +14.5% | -58.9% | at low |
| 5 y | 5-year | -44.4% | +158.1% | -76.0% | +68.4% |
| alltime | all time | -44.4% | +158.1% | -76.0% | +68.4% |
Prelude Therapeutics Incorporated Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 7.04(-10.1%) |
| Jun 2024 | - | 7.83(-32.7%) |
| Mar 2024 | - | 11.64(+7.9%) |
| Dec 2023 | 10.79(+14.5%) | 10.79(-22.4%) |
| Sep 2023 | - | 13.91(-18.8%) |
| Jun 2023 | - | 17.13(+92.3%) |
| Mar 2023 | - | 8.91(-5.4%) |
| Dec 2022 | 9.42 | 9.42(-10.5%) |
| Sep 2022 | - | 10.52(-33.1%) |
| Jun 2022 | - | 15.72(-6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 16.80(+9.3%) |
| Dec 2021 | 15.37(-20.8%) | 15.37(-7.2%) |
| Sep 2021 | - | 16.57(-29.4%) |
| Jun 2021 | - | 23.48(-20.1%) |
| Mar 2021 | - | 29.38(+51.4%) |
| Dec 2020 | 19.41(+364.4%) | 19.41(-7.4%) |
| Sep 2020 | - | 20.96(+285.3%) |
| Jun 2020 | - | 5.44(+30.1%) |
| Dec 2019 | 4.18(-34.4%) | 4.18 |
| Dec 2018 | 6.37 | - |
FAQ
- What is Prelude Therapeutics Incorporated annual current ratio?
- What is the all time high annual current ratio for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual current ratio year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly current ratio?
- What is the all time high quarterly current ratio for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly current ratio year-on-year change?
What is Prelude Therapeutics Incorporated annual current ratio?
The current annual current ratio of PRLD is 10.79
What is the all time high annual current ratio for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual current ratio is 19.41
What is Prelude Therapeutics Incorporated annual current ratio year-on-year change?
Over the past year, PRLD annual current ratio has changed by +1.37 (+14.54%)
What is Prelude Therapeutics Incorporated quarterly current ratio?
The current quarterly current ratio of PRLD is 7.04
What is the all time high quarterly current ratio for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly current ratio is 29.38
What is Prelude Therapeutics Incorporated quarterly current ratio year-on-year change?
Over the past year, PRLD quarterly current ratio has changed by -4.60 (-39.52%)